Limitations in assessing the severity of aortic stenosis by Doppler gradients

Continuous wave Doppler echocardiography was performed before cardiac catheterisation in 69 consecutive patients with suspected aortic stenosis. Agreement between the maximum and the mean Doppler gradients and catheterisation gradients was good. Doppler echocardiography, however, systematically underestimated the maximum and mean gradients, particularly in the high range. Stepwise regression analysis of the small pressure difference between the two methods showed that it could not be explained by age, sex, stroke volume, differences in heart rate, ejection fraction, the presence of coronary artery disease, or severity of aortic regurgitation. There was a negative curvilinear correlation between the maximum and mean Doppler gradients and the aortic valve areas that were measured at catheterisation in patients with pure aortic stenosis. The degree of correlation decreased when patients with concomitant aortic regurgitation were included. The scatter of gradients above and below the correlation line was large and this was caused by low and high transvalvar flow. These results show that the usefulness of Doppler gradients for judging the severity of aortic stenosis, both in relation to immediate diagnosis and follow up, is severely limited if transvalvar flow is not taken into account.

Left ventricular diastolic function in young long-term type 1 (insulin-dependent) diabetic men during exercise assessed by digitized echocardiography

Digitized M-mode echocardiograms were obtained during semisupine bicycle exercise in 10 relatively young (less than 40 years) long-term (greater than or equal to 12 years) type 1 (insulin-dependent) diabetic men, without overt heart disease, and 10 controls. Recordings were done at rest and during workloads of 50 and 100 W. At rest, heart rate was similar in the groups, while at peak exercise it was higher in the diabetics whose left ventricular (LV) end-diastolic dimension was smaller at all study phases. From baseline to peak exercise the diastolic period decreased in both groups, while the LV diastolic peak rate of dimension increase, normalized for end-diastolic dimension, the rapid filling period and the LV dimension change during this period increased. The normalized peak rates of dimension increase and heart rates correlated positively in the groups. However, diabetics had a lower normalized peak rate of dimension increase after adjusting for heart rate by covariance analysis, both at rest (18%) and during peak exercise (20%). Thus, compared to controls, this well defined group of type 1 diabetic men had a consistent subclinical decrease in their peak rate of dimension increase, both at rest and during exercise. Furthermore, the peak rate of dimension increase remained lower in the diabetic subjects after normalization for their smaller end-diastolic dimension and after adjustment for their higher heart rate.

Echocardiographic decision-making for replacement surgery in mitral valve prolapse

The clinical usefulness of M-mode echocardiography for predicting severe mitral regurgitation (MR) requiring valve replacement was assessed in 16 men and 10 women with mitral valve prolapse (MVP) as sole primary cardiac disorder. From left ventricular (LV) angiography, MR was classified as none to moderate (8 cases, group A) or severe (18 cases, group B). At echocardiography, increased LV end-diastolic and end-systolic and left atrial (LA) dimensions, corrected for body-surface area, distinguished group B from group A, with the best validities for LA and LV end-diastolic values. The mean echocardiographic LV fractional shortening and ejection fraction (EF) and the angiographic EF were similar in both groups. Echocardiographic and angiocardiographic LV EF correlated poorly, the former usually overestimating the latter. LV end-diastolic and mean pulmonary capillary wedge pressures were highest in group B, and the latter correlated with echocardiographic LA size. Mitral valve replacement was subsequently performed on 15 of the 18 group B patients. M-mode echocardiography is a valuable adjuvant to clinical assessment of MVP for predicting MR severity and for time-planning of cardiac catheterization or mitral valve surgery.

Digitized echocardiographic measurements of left ventricular function: reproducibility and physiological factors influencing the method

The variability of digitized M-mode echocardiographic measurements and the potential influence of physiological factors on these was studied in 28 relatively young (less than 50 years) healthy subjects. All had heart rates within the normal range. Echocardiographic recordings were standardized in the end-expiratory phase. The coefficients of variation for direct echocardiographic measurements were less than or equal to 6% and for most digitized time derived variables less than or equal to 15%. They were generally greater for inter- than for intracycle comparisons. In systole, the peak shortening rate and the time period from the start of systole to the point of peak shortening rate showed the best reproducibility, while in diastole the peak filling rate, the rapid filling period and the percentage filling during the same period. In multivariate analysis, age and heart rate were found to influence the digitized derived systolic but not the diastolic variables. Their influence, however, on digitized echocardiographic measurements may vary with study subjects selection and should be considered when interpreting results.

Left ventricular thrombi after short-term high-dose anticoagulants in acute myocardial infarction

To examine the effect of short-term, high-dose anticoagulation on the subsequent occurrence of left ventricular (LV) thrombi after a first anterior wall acute myocardial infarction (AMI), 21 patients received placebo and 21 high-dose anticoagulants during the first 10 days of the acute infarction. They were studied with cross-sectional echocardiography 10 days and 1.3 and 6 months post infarction. At 1 month, 6 of 7 thrombi present in the placebo group at 10 days were still visible. No thrombi were detected at 10 days in the anticoagulation group, but 6 patients had developed a LV thrombus at 1 month. These 12 patients with LV thrombi were subsequently treated with oral warfarin for 2 months, after which all thrombi had disappeared. Warfarin was then discontinued, and a thrombus had recurred in 5 patients after 6 months. Apical akinesis at 10 days was a predictor for thrombus with a sensitivity and specificity of 100% and 72.2%, respectively. Three of the 13 patients with LV thrombi suffered stroke in contrast to none without thrombi (P = 0.025). We conclude that after discontinuation of short-term high-dose anticoagulation therapy in anterior AMI, LV thrombi may develop rapidly and lead to embolic complications, particularly in patients with persisting apical akinesis.

Subclinical left ventricular abnormalities in young subjects with long-term type 1 diabetes mellitus detected by digitized M-mode echocardiography

Noninvasive studies in patients with type 1 diabetes mellitus suggest subclinical left ventricular (LV) impairment, but the studies differ with regard to methods, patient selection and results. Thus, digitized M-mode echocardiograms were recorded in 24 persons younger than 50 years with long-term (more than 12 years) type 1 diabetes but without overt heart disease and in 28 control subjects. To improve accuracy, measurements were adjusted for body surface area, LV size and the influence of heart rate, as appropriate. Diabetics had a higher heart rate and systolic and diastolic blood pressure than control subjects. LV end-diastolic and stroke dimensions were smaller, duration of systole longer and preejection period/LV ejection time ratio higher than in control subjects, whereas fractional shortening and peak shortening rate were similar. In diabetics, diastole was shorter, peak filling rate was lower and the rapid filling period was prolonged, while percent filling during the rapid filling period and atrial contribution to filling were higher. Thus, in a well defined study population of relatively young persons with long-term type 1 diabetes, subclinical LV systolic and diastolic dysfunction were found. The diastolic abnormalities suggest reduced LV compliance, while those in systole may be secondary to an increased afterload or decreased myocardial contractility.

Increased occurrence of left ventricular thrombi during early treatment with timolol in patients with acute myocardial infarction

To examine whether early intervention with timolol influences the occurrence of left ventricular thrombi in acute anterior myocardial infarction, 40 patients with acute anterior myocardial infarction admitted to hospital within 6 hr of onset of symptoms were randomly assigned to receive intravenous followed by oral timolol maleate or placebo. Five (25%) of 20 patients in the placebo group and 14 (73.7%) of 19 patients with confirmed infarction in the timolol group developed a left ventricular apical thrombus as detected by two-dimensional echocardiography from 2 to 10 days after inclusion (p less than .005). Patients received anticoagulants only after a left ventricular thrombus had been diagnosed. Only one patient with thrombus suffered peripheral embolization (timolol group). The treatment groups were comparable with respect to location of regional left ventricular dysfunction, electrocardiographic changes, and infarct size estimated by creatine kinase release. However, computer-assisted regional wall motion analysis demonstrated significantly reduced apical wall motion in the timolol group compared with the placebo group (p less than .01). Also, the mean heart rate during the first 10 days after the acute infarction was reduced by 13% in the timolol group (p less than .001). The reduction in heart rate and left ventricular apical wall motion caused by timolol in patients with acute anterior myocardial infarction may increase the occurrence of left ventricular thrombi.

Serum potassium concentrations are inversely related to ventricular, but not to atrial, arrhythmias in acute myocardial infarction

In a study of 1033 consecutive patients with acute myocardial infarction, serum potassium concentrations were determined on admission to hospital and studied with respect to the subsequent occurrence of atrial fibrillation and flutter and of ventricular tachycardia and fibrillation. The study cohort fulfilled the inclusion criteria for the Norwegian timolol trial in which they later took part. In multivariate analysis, with serum potassium concentrations as a continuous variable, age, the presence of ventricular tachycardia and fibrillation, and maximum level of aspartate aminotransferase greater than four times the upper limit of normal were significantly associated with the occurrence of atrial fibrillation and flutter, while serum potassium concentration was not. Serum potassium concentrations and time from onset of the infarction to hospital admission were significantly negatively associated with the occurrence of ventricular tachycardia and fibrillation; while age, cardiomegaly, transient hypotension, pathological Q-waves in the electrocardiogram, atrial fibrillation and flutter, and ventricular premature beats were positively related to these arrhythmias. Thus, there is an independent inverse relationship between serum potassium concentrations and ventricular arrhythmias in acute myocardial infarction.

Circulating catecholamine and potassium concentrations early in acute myocardial infarction: effect of intervention with timolol

In a prospective study, 20 patients with a first acute myocardial infarction and no current treatment with diuretics or cardioactive drugs were randomized to treatment with intravenous timolol (10 patients) or placebo (10 patients). Plasma adrenaline, noradrenaline, and serum potassium were estimated at baseline (mean +/- SD 3.6 +/- 0.8 hours after the onset of the infarction) and 4 hours after the start of treatment. The patient selection criteria embraced a low-risk study population. Before treatment, the serum potassium concentrations correlated inversely with plasma adrenaline but not with plasma noradrenaline concentrations. A rise of serum potassium (mean +/- SD mmol/L) from 4.1 +/- 0.3 to 4.4 +/- 0.4 (p less than 0.05) in the placebo group and from 4.0 +/- 0.4 to 4.5 +/- 0.5 (p less than 0.05) in the timolol group was in multivariate analysis associated with infarct size, estimated as cumulative creatine kinase release, in the placebo group, and with the mean individual plasma adrenaline concentrations in the timolol group. By reversing the effect of adrenaline from a decrease to an increase in the serum potassium concentrations, timolol changes the relationships between circulating adrenaline, potassium, and infarct size.

Malignant arrhythmia in relation to serum potassium in acute myocardial infarction

Several studies of patients with acute myocardial infarction have shown an association between hypokalemia, including mild hypokalemia, and increased occurrence of cardiac arrhythmia. Hypokalemia in acute myocardial infarction is significantly associated with diuretic therapy before or during the infarction. In a study of 1,074 patients with acute myocardial infarction, ventricular fibrillation occurred in 17.2% of 122 hypokalemic patients and in 7.5% of 952 normokalemic patients (p less than 0.01). The association of hypokalemia and ventricular fibrillation was not specifically related to poor left ventricular function. Recent studies indicate that hypokalemia is an independent risk factor of ventricular arrhythmia early in acute myocardial infarction, but a definite causal role of potassium remains to be shown. The importance of catecholamines versus serum potassium levels in occurrence of arrhythmia has not been clarified.

Usefulness of high-dose anticoagulants in preventing left ventricular thrombus in acute myocardial infarction

Fifty-three patients with a suspected first anterior wall acute myocardial infarction (AMI) were randomized to intervention with intravenous heparin followed by oral warfarin (26 patients) or matching placebo (27 patients). The regimen was started within 12 hours after the onset of AMI. Anticoagulation was maintained at a therapeutic level (for heparin, activated partial thromboplastin time 70 to 140 seconds; for warfarin, thrombotest 5 to 10%) for 10 days, and no bleeding episodes occurred. The baseline characteristics of the 2 study groups were well matched. In 7 patients in the placebo group and in none in the anticoagulant group, left ventricular thrombus developed during the study, as detected by serial 2-dimensional echocardiography. Early intervention with high-dose anticoagulant drugs may prevent the development of left ventricular thrombus in anterior wall AMI.

Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction

Sixty patients with a first acute myocardial infarction and no current treatment with cardioactive drugs were included in a prospective study of the relationship between serum potassium concentration and the early occurrence of ventricular tachycardia and premature ventricular contractions (PVCs). Serum potassium level (range 2.5 to 5 mmol/liter) was estimated 3.8 +/- 2.5 hr (mean +/- SD) after the onset of the infarction, and Holter monitoring was performed during the subsequent 12 hr. In multivariate analysis, serum potassium level was negatively and age positively related to ventricular tachycardia. Among the subclasses of PVCs (frequent unifocal, multifocal, couplets, bigeminy), serum potassium concentration was negatively related to the frequent unifocal subclass; hypertension was related to couplets and to the presence of any of the subclasses, and serum aspartate aminotransferase concentration was related to multifocal PVCs. Heart failure leading to death was related to all subclasses of PVC. Serum potassium concentration is an independent inverse predictor of the occurrence of ventricular tachycardia and frequent unifocal PVCs early in acute myocardial infarction.

Effect of timolol on changes in serum potassium concentration during acute myocardial infarction

One hundred and six patients with acute myocardial infarction admitted to hospital within four hours after the onset of symptoms were randomised to treatment with intravenous timolol (54 patients) or placebo (52 patients). Serum potassium concentrations were estimated at frequent intervals during the first 24 hours of admission. Patients in both treatment groups, who did not receive subsequent diuretic treatment, had a transient rise in serum potassium concentration, which was maximal after four hours. This rise was abolished by diuretic treatment in the placebo group but not in the timolol group, in which there was a pronounced and prolonged rise in serum potassium concentration. The change in serum potassium concentration in the first four hours after admission correlated with cumulative creatine kinase release in the placebo group, but not in the timolol group. Hypokalaemia (serum potassium concentration less than or equal to 3.5 mmol/l) occurred in 15 (28.8%) patients in the placebo group and in seven (13%) in the timolol group and was independent of infarct size. The frequency of hyperkalaemia was not increased in the timolol group. By increasing the serum potassium concentration and preventing hypokalaemia, the use of intravenous timolol early in acute myocardial infarction may have important clinical effects in addition to reducing infarct size.

Left ventricular thrombosis and cerebrovascular accident in acute myocardial infarction

In a prospective study of 90 consecutive patients with acute myocardial infarction, 15 (28.3%) of 53 patients with an anterior wall infarction developed a left ventricular thrombosis diagnosed by cross sectional echocardiography. Patients received anticoagulants only after a left ventricular thrombosis had been diagnosed. Twenty eight patients had an inferior infarction, but none of these had a left ventricular thrombosis. Five (5.5%) of the 90 patients suffered a cerebrovascular accident, and all had an anterior wall infarction. In four of these five patients a left ventricular thrombosis was confirmed by echocardiography before the cerebrovascular accident. All patients with left ventricular thrombosis had apical akinesis. The incidence of a thrombosis did not differ in patients with a first anterior myocardial infarction and with reinfarctions. Among the 40 patients with a first anterior wall infarction, 12 with a thrombosis had a significantly higher incidence of enlarged heart on chest radiographs and significantly higher serum aspartate aminotransferase enzyme activity than those without. Thus patients with a large anterior wall infarction and with akinesis in the apical region are at high risk of developing a left ventricular thrombosis, which may be a source of peripheral emboli. Left ventricular thrombosis appears to be rare with infarctions in other locations.

Hypokalaemia and ventricular fibrillation in acute myocardial infarction

Serum potassium concentrations obtained on admission to hospital were inversely related to the incidence of ventricular fibrillation in 289 women and 785 men with acute myocardial infarction, 92 of whom developed ventricular fibrillation. Hypokalaemia (serum potassium concentration less than or equal to 3.5 mmol/l) was found in 122 patients (11.4%). The incidence of ventricular fibrillation was significantly greater in patients with hypokalaemia compared with those classified as normokalaemic (serum potassium concentration greater than or equal to 3.6 mmol/l) (17.2% v 7.4%). The increased risk of ventricular fibrillation in the hypokalaemic group was about the same for women and men. While they were in hospital patients with hypokalaemia developed ventricular fibrillation significantly earlier than did normokalaemic patients (median 0.3 hours v 7 hours). Hypokalaemia was more common in women (17.3%) than in men (9.2%), and 55% of the hypokalaemic patients had been treated with diuretics before admission compared with 22% of the normokalaemic group. Hypokalaemia on admission to hospital predicts an increased likelihood and early occurrence of ventricular fibrillation in patients with acute myocardial infarction.